Commentary

Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality

Author and Disclosure Information

 

References

A full-body skin examination is a time-consuming process. Patients who come to their physician for a routine annual physical don’t expect a skin examination and very few physicians have the time for a long detailed full-body skin examination. When the patient presents to a dermatologist for an examination, it often is because they have real concerns; for example, they may have had a family member who died of skin cancer, or the patient themself may have noticed a worrisome lesion. Patients, not physicians, are the drivers of skin cancer screening, a fact that often is dismissed by those who are not necessarily supportive of the practice.

In light of the findings of Patel et al,4 it is essential that the USPSTF reviews be reanalyzed to compare skin cancer–specific mortality, all-cause mortality, and lifespan in individuals who pursue skin cancer screening; the reanalysis also should not be exclusively limited to survival. With the advent of the immune checkpoint inhibitors, patients with metastatic melanoma are living much longer.11 The burden of living with metastatic cancer must be characterized and measured to have a complete picture and a valid analysis.

After the release of the USPSTF recommendation, there have been calls for large-scale studies to prove the benefits of skin cancer screening.12 Such studies may be valuable; however, if the hypothesis that overall healthy behavior as the major outcome determinant is substantiated, it may prove quite challenging to perform tests of association with specific interventions. It has been shown that skin cancer screening does lead to discovery of more melanomas,13 yet in light of the paradox described by Patel et al,4 it also is likely that causes of death other than melanoma impact overall mortality. Patients who pursue skin examinations may engage in multiple different health activities that are beneficial in the long term, making it difficult to analyze the specific benefit of skin cancer screening in isolation. It may prove difficult to ask patients to omit selected aspects of healthy behavior to try to prove the point. At this time, there is much more work to be done prior to offering opinions on the importance of skin cancer examination in isolation to improve overall health care. In the meantime, dermatologists owe it to our patients to continue to diligently pursue thorough and detailed skin examinations.

Pages

Recommended Reading

Incipient ulceration may affect prognosis in primary melanoma
MDedge Dermatology
Actinic keratoses may predict skin cancers in older adults
MDedge Dermatology
Sharps injuries are common among Mohs surgeons, survey finds
MDedge Dermatology
Lower-extremity lymphedema associated with more skin cancer risk
MDedge Dermatology
Aberrant Expression of CD56 in Metastatic Malignant Melanoma
MDedge Dermatology
New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives
MDedge Dermatology
PRAME Expression in Melanocytic Proliferations in Special Sites
MDedge Dermatology
Coming Soon: The First mRNA Vaccine for Melanoma?
MDedge Dermatology
FDA Clears AI-Powered Device for Noninvasive Skin Cancer Testing
MDedge Dermatology
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
MDedge Dermatology